HER2-postive cancers displayed significantly higher GrayLevelNonUniformityNormalized (GLNUN), SizeZoneNonUniformityNormalized (SZNUN), InverseVariance, ZonePercentage and Imc1, as compared with HER2-negative cancers. Here, ERBB2 is linked to cancer.